Cargando…

The effectiveness of enhanced evidence-based care for depressive disorders: a meta-analysis of randomized controlled trials

Several care models have been developed to improve treatment for depression, all of which provide “enhanced” evidence-based care (EEC). The essential component of these approaches is Measurement-Based Care (MBC). Specifically, Collaborative Care (CC), and Algorithm-guided Treatment (AGT), and Integr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Le, Qi, Han, Zheng, Wei, Xiang, Yu-Tao, Carmody, Thomas J., Mayes, Taryn L., Trivedi, Madhukar H., Wang, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520525/ https://www.ncbi.nlm.nih.gov/pubmed/34657142 http://dx.doi.org/10.1038/s41398-021-01638-7

Ejemplares similares

Considering depression as a secondary outcome in the optimization of physical activity interventions for breast cancer survivors in the PACES trial: a factorial randomized controlled trial
por: Rethorst, Chad D., et al.
Publicado: (2023)

Addressing adherence to antidepressant treatment for depression
por: Mayes, Taryn L., et al.
Publicado: (2020)

The 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR(9)) measure of suicidal risk: Performance in adult primary care patients
por: Nandy, Karabi, et al.
Publicado: (2023)

Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR(16)) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized Trial
por: Trombello, Joseph M, et al.
Publicado: (2023)

A Systematic Review and Meta-Analysis of Depression and Protein–Energy Wasting in Kidney Disease
por: Gregg, L. Parker, et al.
Publicado: (2019)

Multi-Omics Characterization of Early- and Adult-Onset Major Depressive Disorder
por: Grant, Caroline W., et al.
Publicado: (2022)

The Concise Health Risk Tracking ‐ Self‐Report (CHRT‐SR)—A measure of suicidal risk: Performance in adolescent outpatients
por: Nandy, Karabi, et al.
Publicado: (2022)

Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder
por: Grant, Caroline W., et al.
Publicado: (2022)

Fibroblast growth factor 21 (FGF21) is increased in MDD and interacts with body mass index (BMI) to affect depression trajectory
por: Mason, Brittany L., et al.
Publicado: (2022)

Item response analysis of the inventory of depressive symptomatology
por: Bernstein, Ira H, et al.
Publicado: (2006)

Psychometric and Clinical Evaluation of the Clinician (VQIDS-C(5)) and Self-Report (VQIDS-SR(5)) Versions of the Very Quick Inventory of Depressive Symptoms
por: Rush, A John, et al.
Publicado: (2022)

Leveraging the microbiome to understand clinical heterogeneity in depression: findings from the T-RAD study
por: Chin Fatt, Cherise R., et al.
Publicado: (2023)

Treatment strategies to improve and sustain remission in major depressive disorder
por: Madhukar H., Trivedi, et al.
Publicado: (2008)

Pro-Inflammatory Cytokines as Predictors of Antidepressant Effects of Exercise in Major Depressive Disorder
por: Rethorst, Chad D., et al.
Publicado: (2012)

Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients
por: Jha, Manish K., et al.
Publicado: (2016)

Adaption of tele-behavioral activation to increase physical activity in depression: Protocol for iterative development and evaluation
por: Rethorst, Chad D., et al.
Publicado: (2023)

Evidence for machine learning guided early prediction of acute outcomes in the treatment of depressed children and adolescents with antidepressants
por: Athreya, Arjun P., et al.
Publicado: (2022)

The Quick Inventory of Depressive Symptomatology, Adolescent Version (QIDS-A(17)): A Psychometric Evaluation
por: Haley, Charlotte L, et al.
Publicado: (2023)

Depression education fotonovela for engagement of Hispanic patients in treatment: a randomized clinical trial
por: Sanchez, Katherine, et al.
Publicado: (2021)

Correction: Depression education fotonovela for engagement of Hispanic patients in treatment: a randomized clinical trial
por: Sanchez, Katherine, et al.
Publicado: (2023)

Biomarkers and the Future of Treatment for Depression
por: Toups, Marisa, et al.
Publicado: (2012)

Immune characterization of suicidal behavior in female adolescents
por: Chin Fatt, Cherise R., et al.
Publicado: (2022)

Montgomery‐Åsberg Depression Rating Scale factors in treatment‐resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine
por: Borentain, Stephane, et al.
Publicado: (2022)

Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication
por: Joyce, Jeremiah B., et al.
Publicado: (2021)

IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder
por: Rethorst, C D, et al.
Publicado: (2015)

Circulating microRNA associated with future relapse status in major depressive disorder
por: Li, Qingqin S., et al.
Publicado: (2022)

Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial
por: Giles, Michael A., et al.
Publicado: (2023)

Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies
por: Fava, Maurizio, et al.
Publicado: (2018)

Low-quality of patient-reported outcome reporting in randomized clinical trials of major depressive disorder—a meta-epidemiological review
por: Zhou, Jia, et al.
Publicado: (2023)

A complier average causal effect analysis of the Stimulant Reduction Intervention using dosed exercise study
por: Carmody, Thomas, et al.
Publicado: (2018)

A review of quetiapine in combination with antidepressant therapy in patients with depression
por: Daly, Ella J, et al.
Publicado: (2007)

A COMPREHENSIVE EXAMINATION OF WHITE MATTER TRACTS AND CONNECTOMETRY IN MAJOR DEPRESSIVE DISORDER
por: Olvet, Doreen M., et al.
Publicado: (2015)

Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial
por: Cooper, Crystal M., et al.
Publicado: (2019)

Accurately identifying patients who are excellent candidates or unsuitable for a medication: a novel approach
por: South, Charles, et al.
Publicado: (2017)

Effect of Cognitive Behavioral Therapy Versus Interpersonal Psychotherapy in Patients with Major Depressive Disorder: A Meta-analysis of Randomized Controlled Trials
por: Zhou, She-Gang, et al.
Publicado: (2017)

Adverse Effects of Esketamine for the Treatment of Major Depression Disorder: Findings from Randomized Controlled Trials
por: Yang, Siyuan, et al.
Publicado: (2021)

Does Duloxetine Improve Cognitive Function Independently of Its Antidepressant Effect in Patients with Major Depressive Disorder and Subjective Reports of Cognitive Dysfunction?
por: Greer, Tracy L., et al.
Publicado: (2014)

Huperzine A for treatment of cognitive impairment in major depressive disorder: a systematic review of randomized controlled trials
por: ZHENG, Wei, et al.
Publicado: (2016)

Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder
por: Connor, Kathryn M, et al.
Publicado: (2017)

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
por: Jha, Manish K, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gackauura58u7bs7hci60glo4f